Skip to main content

Opioids in Abdominal Pain

  • Chapter
  • First Online:
Chronic Abdominal Pain

Abstract

The use of opioids in the setting of abdominal pain has nearly doubled in the last decade, making it a commonplace yet controversial practice. Although initially used predominantly for cancer pain and acute conditions, opioid use for chronic noncancerous pain has steadily increased along with the rates of abuse, misuse, and diversion. The variety of agents available have equally increased in recent years, giving the prescriber much to consider when weighing the drug’s properties with patient-related factors and special issues specific to opioids in the gastrointestinal tract. In light of the variables ultimately leading to the patient’s response, the opioid agent is often changed to a different type of formulation in order to maintain efficacy and minimize side effects. Overall, opioids must be prescribed on an individual basis with frequent monitoring for benefits as well as side effects and evidence of abuse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. US Department of Health and Human Services, NCHS. Data from the National Hospital Ambulatory Medical Care Survey: 1999–2008. ER department visits for chest pain and abdominal pain: United States. http://www.cdc.gov/nchs/data/databriefs/db43.htm. Accessed 6 Sept 2013.

  2. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179–87.

    Article  PubMed Central  PubMed  Google Scholar 

  3. International Association of Pain. Global year against visceral pain October 2012–October 2013. Epidemiology of abdominal pain. http://www.iasp-pain.org/AM/Template.cfm?Section=Fact_Sheets5%26Template=/CM/ContentDisplay.cfm%26ContentID=16193. Accessed 25 Sept 2013.

  4. Jones AD, Ramakrishnan K. Analgesics in the initial management of acute abdominal pain. Internet J Emerg Med. 2005;2(2). Doi: 10.5580/22ac.

  5. Drossman DA. Severe and refractory chronic abdominal pain: treatment strategies. Clin Gastroenterol Hepatol. 2008;6(9):978–82.

    Article  CAS  PubMed  Google Scholar 

  6. Smith HS, et al. Current therapy in pain. Philadelphia: Saunders Elsevier; 2009.

    Google Scholar 

  7. Manterola C, Astudillo P, et al. Analgesia in patients with acute abdominal pain. Cochrane Database Syst Rev. 2011;19(1), CD005660.

    Google Scholar 

  8. Ranji SR, Goldman LE, et al. Do opiates affect the clinical evaluation of patients with acute abdominal pain? JAMA. 2006;296(14):1764–74.

    Article  CAS  PubMed  Google Scholar 

  9. Australian Government National Health and Research Council. National Institute of Clinical Studies Emergency Care Community of Practice. Evidence in Practice Series 2008. Pain medication for acute abdominal pain, a summary of best available evidence and information on clinical practice. http://www.nhmrc.gov.au/_files_nhmrc/file/nics/material_resources/pain_medication_

  10. aute_abdominal_pain.pdf. Accessed 24 Sept 2013.

    Google Scholar 

  11. Matthew D, Hsien-Yen C, Yuping Y, Viswanathan S, Shah N, Stafford R, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Med Care. 2013;51(10):870. doi:10.1097/MLR.0b013e3182a95d86.

    Article  Google Scholar 

  12. Gerson LB. Gastroenterologists and the US epidemic. Gastroenterology. 2012;142(5):1250–3.

    Article  PubMed  Google Scholar 

  13. Dorn SD, Meek PD, Shah NS. Increasing frequency of opioid prescriptions for chronic abdominal pain in the US outpatient clinics. Clin Gastroenterol Hepatol. 2011;9(12):1078–85.

    Article  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(23):705–9.

    Google Scholar 

  15. Berland D, Rodgers P. Rational use of opioids for management of chronic nonterminal pain. Am Fam Physician. 2012;86(3):252–8.

    PubMed  Google Scholar 

  16. Chou FR, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of a aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–46.

    Article  CAS  PubMed  Google Scholar 

  18. Ramsin B, Trescot AM, Datta SM, Benyamin MD, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–20.

    Google Scholar 

  19. Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM. Essentials of pain medicine and regional anesthesia. 2nd ed. Philadelphia: Elsevier; 2005.

    Google Scholar 

  20. Epstein H, Hansen C, Thorson D. A protocol for addressing acute pain and prescribing opioids. Minn Med. 2014;97(4):47–51.

    PubMed  Google Scholar 

  21. Koneru A, Satyanarayana S, Rizwan S. Endogenous opioids: their physiological role and receptors. Global J Pharmacol. 2009;3(3):149–53.

    Google Scholar 

  22. Argoff CE, Silvershein DI. Comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc. 2009;84(7):602–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Supplement):11S–8.

    Article  CAS  PubMed  Google Scholar 

  24. Panchal SJ, Muller-Schwefe PM, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology, and burden. Int J Clin Pract. 2007;61(7):1181–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Pasternak GW. Opioids and their receptors, are we there yet? Neuropharmacology. 2014;76 Pt B:198–203.

    Google Scholar 

  26. Helm JF, et al. Effects of morphine on the human sphincter of Oddi. Gut. 1988;29(10):1402–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Hubbard GP, Wolfe KR. Meperidine misuse in a patient with sphincter of Oddi dysfunction. Ann pharmacother. 2003;37(4):534–7.

    Article  PubMed  Google Scholar 

  28. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96(4):1266–72.

    Article  CAS  PubMed  Google Scholar 

  29. Wu SD, et al. Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary Pancreat Dis Int. 2003;2(1):121–5.

    CAS  PubMed  Google Scholar 

  30. Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10(6):209–19.

    Article  CAS  PubMed  Google Scholar 

  31. Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after afferent routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990;47:12–9.

    Article  CAS  PubMed  Google Scholar 

  32. Fine PG, Portenoy RK. Strategies for opioid rotation: decision support in chronic pain management. MedScape Education. 2010. http://cme.medscape.com/viewarticle/717832. Accessed 30 Mar 2010.

  33. Fine PG, Portenoy RK. For the ad hoc expert panel on evidence review and guidelines for opioid rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38:418–25.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Fine PG, Portenoy RK. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38(3):418–25.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Fine PG, Portenoy RK. A clinical guide to opioid analgesia. New York: Vendome Group, LLC; 2007.

    Google Scholar 

  36. Thomsen AB, Becker N, Eriksen J. Opioid rotation in chronic non-malignant pain patients: a retrospective study. Acta Anaesthesiol Scand. 1999;43(9):918–23.

    Article  CAS  PubMed  Google Scholar 

  37. Pasternak GW. Molecular biology of opioid analgesia. J Pain Symptom Manage. 2005;29(5 suppl):S2–9.

    Article  CAS  PubMed  Google Scholar 

  38. Shooke JE, Pelton JT, Hurby VJ, et al. Peptide opioid antagonist separates peripheral and central antitransit effects. J Pharmacol Exp Ther. 1987;243:492–500.

    Google Scholar 

  39. Manara L, Bianchetti A. The central and peripheral influences of opioids on the gastrointestinal propulsion. Annu Rev Pharmacol Toxicol. 1985;25:249–73.

    Article  CAS  PubMed  Google Scholar 

  40. Margolin S. Decreased gastrointestinal propulsive activity after intracranial morphine. Fed Proc. 1954;13:383–4.

    Google Scholar 

  41. Tamayo AC, Diaz-Zuluaga PA. Management of opioid-induced bowel dysfunction in cancer patients. Support Care Cancer. 2004;12:613–8.

    PubMed  Google Scholar 

  42. Mancini I, Bruera E. Constipation in advanced cancer patients. Support Care Cancer. 1998;6:356–64.

    Article  CAS  PubMed  Google Scholar 

  43. Wilder-Smith C, Betiga A. The analgesic tramadol has minimal effect on motor gastrointestinal function. Br J Clin Pharmacol. 1997;43:71–5.

    Article  CAS  PubMed  Google Scholar 

  44. Daenick P, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage. 1999;18:303–9.

    Article  Google Scholar 

  45. Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000;14:111–9.

    Article  CAS  PubMed  Google Scholar 

  46. Benzon H, Rathmell J, et al. Raj’s practical pain management. 4th ed. Philadelphia: Mosby Elsevier; 2008.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehul J. Desai M.D., M.P.H. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gutierrez, G.J., Rodante, J., Desai, M.J. (2015). Opioids in Abdominal Pain. In: Kapural, L. (eds) Chronic Abdominal Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1992-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1992-5_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1991-8

  • Online ISBN: 978-1-4939-1992-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics